BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10109602)

  • 1. The growing crackdown on laboratory fraud and abuse.
    Albertson D
    MLO Med Lab Obs; 1991 Feb; 23(2):24-9. PubMed ID: 10109602
    [No Abstract]   [Full Text] [Related]  

  • 2. Hanlester Laboratories decision: important test of antikickback statute.
    Tully WB
    Healthspan; 1991 Apr; 8(4):9-12. PubMed ID: 10110667
    [No Abstract]   [Full Text] [Related]  

  • 3. Joint ventures become even riskier.
    Azevedo D
    Med Econ; 1993 Jul; 70(14):36-8, 41, 44-5. PubMed ID: 10127361
    [No Abstract]   [Full Text] [Related]  

  • 4. HHS adopts tough kickback definition.
    Burda D
    Mod Healthc; 1991 Sep; 21(38):2. PubMed ID: 10114126
    [No Abstract]   [Full Text] [Related]  

  • 5. HHS publishes long-awaited fraud and abuse anti-kickback regulations.
    Weissburg C; Conn LC
    Rev Fed Am Health Syst; 1989; 22(2):45-7. PubMed ID: 10303427
    [No Abstract]   [Full Text] [Related]  

  • 6. Update: fraud and abuse and Stark laws.
    Steiner JE
    J Health Hosp Law; 1993 Sep; 26(9):274-82, 288. PubMed ID: 10136108
    [No Abstract]   [Full Text] [Related]  

  • 7. Joint ventures: beyond the safe harbors.
    Kadzielski MA
    Health Prog; 1989 May; 70(4):70, 77. PubMed ID: 10292848
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulating physician investment and referral behavior in the competitive health care marketplace of the '90s--an argument for decentralization.
    King KA
    Spec Law Dig Health Care (Mon); 1991 Apr; (146):7-25. PubMed ID: 10110007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded enforcement of the fraud and abuse laws.
    Peregrine MW; Nodzenski TJ
    J Health Hosp Law; 1990 Jan; 23(1):10-4, 32. PubMed ID: 10106419
    [No Abstract]   [Full Text] [Related]  

  • 10. "Hanlester Laboratories": HHS joint venture standards remain unclear.
    Tully WB
    Healthspan; 1991 Nov; 8(10):8-11. PubMed ID: 10114943
    [No Abstract]   [Full Text] [Related]  

  • 11. Departmental appeals board issues final decision in Hanlester Network case.
    Lindeke JM
    Health Care Law Newsl; 1992 Nov; 7(11):11-4. PubMed ID: 10183756
    [No Abstract]   [Full Text] [Related]  

  • 12. Inspector General v. Hanlester Network: a new fraud and abuse standard?
    Gummerman D
    Med Staff Couns; 1991; 5(4):59-61. PubMed ID: 10183523
    [No Abstract]   [Full Text] [Related]  

  • 13. Hanlester Laboratories decision gives dangerously broad interpretation of federal anti-kickback statute.
    Tully WB; Wirth PH
    Healthspan; 1992 Jun; 9(6):11-4. PubMed ID: 10183678
    [No Abstract]   [Full Text] [Related]  

  • 14. HCFA, IRS, FBI intensify fraud and abuse investigations.
    Albertson D
    MLO Med Lab Obs; 1992 Mar; 24(3):17-8. PubMed ID: 10117427
    [No Abstract]   [Full Text] [Related]  

  • 15. Physician self-referrals: Stark pushing total ban on physician ownership and self-referral deals.
    Margolis RE
    Healthspan; 1993 May; 10(5):14-6. PubMed ID: 10127750
    [No Abstract]   [Full Text] [Related]  

  • 16. SmithKline settles charges of kickbacks at 3 labs.
    Burda D
    Mod Healthc; 1989 Dec; 19(52):3. PubMed ID: 10304218
    [No Abstract]   [Full Text] [Related]  

  • 17. How doctors are bailing out of self-referral facilities.
    Mangan D
    Med Econ; 1993 Feb; 70(3):182-8. PubMed ID: 10124204
    [No Abstract]   [Full Text] [Related]  

  • 18. New fraud & abuse tax issues.
    Integr Healthc Rep; 1993 Feb; ():10-1. PubMed ID: 10128314
    [No Abstract]   [Full Text] [Related]  

  • 19. Narrow 'safe harbors' may create tough choices for hospitals.
    Hudson T
    Hospitals; 1991 Oct; 65(19):32-6. PubMed ID: 1894272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curing the health care industry: government response to Medicare fraud and abuse.
    Hearn FJ
    J Contemp Health Law Policy; 1989; 5():175-201. PubMed ID: 10303502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.